These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 26423886

  • 21. Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice.
    Newberry EP, Xie Y, Kennedy SM, Luo J, Davidson NO.
    Hepatology; 2006 Nov; 44(5):1191-205. PubMed ID: 17058218
    [Abstract] [Full Text] [Related]

  • 22. Beneficial effects of lingonberry (Vaccinium vitis-idaea L.) supplementation on metabolic and inflammatory adverse effects induced by high-fat diet in a mouse model of obesity.
    Ryyti R, Hämäläinen M, Peltola R, Moilanen E.
    PLoS One; 2020 Nov; 15(5):e0232605. PubMed ID: 32379797
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. N-3 long-chain PUFA supplementation prevents high fat diet induced mouse liver steatosis and inflammation in relation to PPAR-α upregulation and NF-κB DNA binding abrogation.
    Tapia G, Valenzuela R, Espinosa A, Romanque P, Dossi C, Gonzalez-Mañán D, Videla LA, D'Espessailles A.
    Mol Nutr Food Res; 2014 Jun; 58(6):1333-41. PubMed ID: 24436018
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice.
    Tsuchida T, Shiraishi M, Ohta T, Sakai K, Ishii S.
    Metabolism; 2012 Jul; 61(7):944-53. PubMed ID: 22154323
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types.
    Buettner R, Parhofer KG, Woenckhaus M, Wrede CE, Kunz-Schughart LA, Schölmerich J, Bollheimer LC.
    J Mol Endocrinol; 2006 Jun; 36(3):485-501. PubMed ID: 16720718
    [Abstract] [Full Text] [Related]

  • 31. Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet.
    Fraulob JC, Souza-Mello V, Aguila MB, Mandarim-de-Lacerda CA.
    Clin Sci (Lond); 2012 Aug 01; 123(4):259-70. PubMed ID: 22420611
    [Abstract] [Full Text] [Related]

  • 32. Maternal and Post-weaning High-Fat Diets Produce Distinct DNA Methylation Patterns in Hepatic Metabolic Pathways within Specific Genomic Contexts.
    Moody L, Wang H, Jung PM, Chen H, Pan YX.
    Int J Mol Sci; 2019 Jun 30; 20(13):. PubMed ID: 31262088
    [Abstract] [Full Text] [Related]

  • 33. Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice.
    Barbosa-da-Silva S, Souza-Mello V, Magliano DC, Marinho Tde S, Aguila MB, Mandarim-de-Lacerda CA.
    Life Sci; 2015 Apr 15; 127():73-81. PubMed ID: 25748419
    [Abstract] [Full Text] [Related]

  • 34. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N.
    Metabolism; 2013 Nov 15; 62(11):1651-61. PubMed ID: 23928105
    [Abstract] [Full Text] [Related]

  • 35. Effect of dietary monosodium glutamate on HFCS-induced hepatic steatosis: expression profiles in the liver and visceral fat.
    Collison KS, Maqbool ZM, Inglis AL, Makhoul NJ, Saleh SM, Bakheet RH, Al-Johi MA, Al-Rabiah RK, Zaidi MZ, Al-Mohanna FA.
    Obesity (Silver Spring); 2010 Jun 15; 18(6):1122-34. PubMed ID: 20111022
    [Abstract] [Full Text] [Related]

  • 36. Gene expression and DNA methylation as mechanisms of disturbed metabolism in offspring after exposure to a prenatal HF diet.
    Rouschop SH, Karl T, Risch A, van Ewijk PA, Schrauwen-Hinderling VB, Opperhuizen A, van Schooten FJ, Godschalk RW.
    J Lipid Res; 2019 Jul 15; 60(7):1250-1259. PubMed ID: 31064776
    [Abstract] [Full Text] [Related]

  • 37. Mice lacking NOX2 are hyperphagic and store fat preferentially in the liver.
    Costford SR, Castro-Alves J, Chan KL, Bailey LJ, Woo M, Belsham DD, Brumell JH, Klip A.
    Am J Physiol Endocrinol Metab; 2014 Jun 15; 306(12):E1341-53. PubMed ID: 24760992
    [Abstract] [Full Text] [Related]

  • 38. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
    Andrade JM, Paraíso AF, de Oliveira MV, Martins AM, Neto JF, Guimarães AL, de Paula AM, Qureshi M, Santos SH.
    Nutrition; 2014 Jun 15; 30(7-8):915-9. PubMed ID: 24985011
    [Abstract] [Full Text] [Related]

  • 39. Effects of excess dietary iron and fat on glucose and lipid metabolism.
    Choi JS, Koh IU, Lee HJ, Kim WH, Song J.
    J Nutr Biochem; 2013 Sep 15; 24(9):1634-44. PubMed ID: 23643521
    [Abstract] [Full Text] [Related]

  • 40. Hepatocyte-specific Ptpn6 deletion promotes hepatic lipid accretion, but reduces NAFLD in diet-induced obesity: potential role of PPARγ.
    Xu E, Forest MP, Schwab M, Avramoglu RK, St-Amand E, Caron AZ, Bellmann K, Shum M, Voisin G, Paquet M, Montoudis A, Lévy E, Siminovitch KA, Neel BG, Beauchemin N, Marette A.
    Hepatology; 2014 May 15; 59(5):1803-15. PubMed ID: 24327268
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.